<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03164811</url>
  </required_header>
  <id_info>
    <org_study_id>Si826/2016</org_study_id>
    <nct_id>NCT03164811</nct_id>
  </id_info>
  <brief_title>GDFT Based on PPV Compared With Standard Fluid Therapy in Patients Undergoing Complex Spine Surgery: RCT</brief_title>
  <official_title>Goal Directed Fluid Therapy Based on Pulse Pressure Variation Compared With Standard Fluid Therapy in Patients Undergoing Complex Spine Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will do the Goal directed fluid therapy by protocolized fluid management in
      the experimental group, using PPV to guide the fluid administration, compare with standard
      fluid management in patients undergoing complex spine surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 11, 2017</start_date>
  <completion_date type="Actual">January 30, 2019</completion_date>
  <primary_completion_date type="Actual">December 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>episode of intraoperative hypotension</measure>
    <time_frame>intraoperative</time_frame>
    <description>Blood pressure will be record continuously using arterial catheter in both group. Number of participants and episode of hypotension (defined as SBP &lt; 90 mmHg or MAP &lt; 60 mmHg or decrease of SPB &gt;= 25% from baseline for 5 minutes or need vasopressor) therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>unit of blood transfusion</measure>
    <time_frame>intraoperative and up to 24 hours postoperatively</time_frame>
    <description>all unit of blood transfusion will be record intraoperative and postoperative</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Spine Disease</condition>
  <arm_group>
    <arm_group_label>GDFT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The GDFT group will receive 400 ml of 12.5% carbohydrate drink after 6 pm until the bed time in the day before surgery and 200 ml in the morning of the surgery day. Acetate ringer solution will be start at 7:00. After induction PPV will be measure and fluid bolus 200 ml in 10 minutes will be given if PPV &gt;13 before prone position. During the operation, the patient in GDFT group will receipt fluid therapy according to acceptable PPV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controlled group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The carbohydrate drink will not be given. Fluid, blood and blood product administration will be under attending anesthesiologist order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>goal directed fluid therapy</intervention_name>
    <description>pulse pressure variation will be used to as a goal to guide fluid administration in this group</description>
    <arm_group_label>GDFT group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Controlled</intervention_name>
    <description>standard fluid treatment by an anesthesiologist</description>
    <arm_group_label>controlled group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1-3

          -  elective surgery

          -  thoracic/lumbar spine surgery &gt;= 3 levels and duration &gt;= 3 hours

        Exclusion Criteria:

          -  Cr &gt;2 mg/dl or eGFR &lt; 60 ml/min

          -  coronary artery disease, congestive heart failure or cardiac arrhythmia

          -  BMI &gt;30 kg/m2

          -  hemodynamic unstable, preoperatively

          -  uncontrolled hypertension

          -  respiratory system compliance &lt; 30 ml/cmH2O
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital</name>
      <address>
        <city>Bangkok Noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 24, 2017</study_first_submitted>
  <study_first_submitted_qc>May 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2017</study_first_posted>
  <last_update_submitted>February 2, 2020</last_update_submitted>
  <last_update_submitted_qc>February 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

